AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8629065 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptomatic therapy followed by diethylcarbamazine citrate (DEC)
Number of subjects: 65
Study 8629065 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptomatic therapy plus antibiotics followed by DEC
Number of subjects: 65
Study 8629065 — intervention group
Group type: EXPERIMENTAL
Intervention: Hygienic measures combined with good foot care and local antibiotic/antifungal cream application
Number of subjects: 65
Study 1792369 — intervention group
Group type: EXPERIMENTAL
Intervention: nisoldipine
Number of subjects: 50
Study 1792369 — intervention group
Group type: COMPARATOR
Intervention: alpha-methyldopa
Number of subjects: 50
Study 6999399 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional high‐voltage irradiation to the pelvic field (4000 rads to the pelvic lymph nodes)
Number of subjects: 540
Study 6999399 — intervention group
Group type: COMPARATOR
Intervention: No further treatment (controls)
Number of subjects: 540
Study 6999399 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with vessel invasion
Number of subjects: 540
Study 29081179 — intervention group
Group type: EXPERIMENTAL
Intervention: ILK-CSC injection (1×10^5 cells/30 μl)
Number of subjects: 40
Study 29081179 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad-null-CSC injection (1×10^5 cells/30 μl)
Number of subjects: 40
Study 29081179 — intervention group
Group type: COMPARATOR
Intervention: Saline injection
Number of subjects: 40
Study 25345912 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 90
Study 25345912 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient group (recurrent epistaxis)
Number of subjects: 90
Study 23438054 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen/ORC/silver therapy
Number of subjects: 39
Study 23438054 — intervention group
Group type: COMPARATOR
Intervention: Control treatment (standard treatment)
Number of subjects: 39
Study 21493994 — intervention group
Group type: COMPARATOR
Intervention: Generic propofol (Group 1)
Number of subjects: 120
Study 21493994 — intervention group
Group type: COMPARATOR
Intervention: Generic propofol with lidocaine (Group 2)
Number of subjects: 120
Study 21493994 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol lipuro (Group 3)
Number of subjects: 120
Study 21493994 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol lipuro with lidocaine (Group 4)
Number of subjects: 120
Study 19269139 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 110
Study 19269139 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 110
Study 19269139 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 110
Study 16862356 — intervention group
Group type: EXPERIMENTAL
Intervention: Pendulum appliance
Number of subjects: 30
Study 16862356 — intervention group
Group type: COMPARATOR
Intervention: Traditional face-bow
Number of subjects: 30
Study 15547019 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiography
Number of subjects: 86
Study 15547019 — intervention group
Group type: COMPARATOR
Intervention: Radionuclide ventriculography
Number of subjects: 86
Study 11360851 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose 5% infusion
Number of subjects: 53
Study 11360851 — intervention group
Group type: COMPARATOR
Intervention: Xylose 5% infusion
Number of subjects: 53
Study 11360851 — intervention group
Group type: COMPARATOR
Intervention: Electrolyte infusion
Number of subjects: 53
Study 9428058 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA) treatment for 4 weeks
Number of subjects: 12
Study 8098392 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid infusion of 125 mL of an aminoacid mixture (Synthamin 14 without electrolytes) over 5 min (2.1 g per min)
Number of subjects: 8
Study 8098392 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid infusion of 50 mL of aminoacids over 5 min
Number of subjects: 8
Study 3318991 — intervention group
Group type: EXPERIMENTAL
Intervention: Reality orientation followed by reminiscence therapy
Number of subjects: 0
Study 3318991 — intervention group
Group type: COMPARATOR
Intervention: Reminiscence therapy
Number of subjects: 0
Study 3318991 — intervention group
Group type: COMPARATOR
Intervention: Reality orientation
Number of subjects: 0
Study 28460406 — intervention group
Group type: EXPERIMENTAL
Intervention: Burst TENS
Number of subjects: 53
Study 28460406 — intervention group
Group type: COMPARATOR
Intervention: Sham burst TENS
Number of subjects: 53
Study 27084667 — intervention group
Group type: EXPERIMENTAL
Intervention: CPG-based clinical decision support system (CDSS) for WSL prevention
Number of subjects: 840
Study 27084667 — intervention group
Group type: COMPARATOR
Intervention: Usual preventive measures
Number of subjects: 840
Study 24557441 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA(®) cream
Number of subjects: 200
Study 24557441 — intervention group
Group type: COMPARATOR
Intervention: Traditional anesthetic technique (lidocaine 10% and 2%)
Number of subjects: 200
Study 24557441 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (EMLA(®) cream and traditional anesthetic)
Number of subjects: 200
Study 24054359 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal ketorolac challenge
Number of subjects: 165
Study 20390497 — intervention group
Group type: EXPERIMENTAL
Intervention: m-DOT (modified-directly observed therapy)
Number of subjects: 94
Study 20390497 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 94
Study 17522928 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1: overnight infusion and a bolus of colloid before induction of anesthesia, followed by a bolus just before pneumoperitoneum (PP)
Number of subjects: 21
Study 17522928 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2: overnight infusion and a colloid bolus before anesthesia
Number of subjects: 21
Study 17522928 — intervention group
Group type: COMPARATOR
Intervention: Control group: received only infusion during operation
Number of subjects: 21
Study 17522928 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 21
Study 17201719 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 27
Study 17201719 — intervention group
Group type: COMPARATOR
Intervention: Supportive Therapy (ST)
Number of subjects: 27
Study 12364992 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic clipping (group I)
Number of subjects: 40
Study 12364992 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic band ligation (group II)
Number of subjects: 40
Study 10227461 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy and autologous stem cell support
Number of subjects: 313
Study 10227461 — intervention group
Group type: COMPARATOR
Intervention: Melphalan-prednisone (initial therapy)
Number of subjects: 313
Study 10227461 — intervention group
Group type: COMPARATOR
Intervention: All patients with symptomatic myeloma
Number of subjects: 313
Study 8572039 — intervention group
Group type: EXPERIMENTAL
Intervention: Estring (estradiol-releasing vaginal ring, 6.5 to 9.5 micrograms per 24 hours)
Number of subjects: 136
Study 8572039 — intervention group
Group type: EXPERIMENTAL
Intervention: Estring (estradiol-releasing vaginal ring)
Number of subjects: 136
Study 1882999 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 80
Study 1882999 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 6337618 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulconazole 1% cream
Number of subjects: 40
Study 6337618 — intervention group
Group type: COMPARATOR
Intervention: Clotrimazole 1% cream
Number of subjects: 40
Study 30556374 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediately loaded group (loaded on the same day as implant insertion)
Number of subjects: 19
Study 30556374 — intervention group
Group type: COMPARATOR
Intervention: Conventionally loaded group (loaded 3 months after implant insertion)
Number of subjects: 19
Study 29019012 — intervention group
Group type: EXPERIMENTAL
Intervention: BOOST-A™ transition planning program
Number of subjects: 72
Study 26762900 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Access (DA) system
Number of subjects: 311
Study 26762900 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 311
Study 24669841 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant IFN‐γ (rIFN‐γ, 100 μg s.c., thrice a week) for 2 weeks
Number of subjects: 8
Study 24669841 — intervention group
Group type: COMPARATOR
Intervention: Standard antifungal therapy
Number of subjects: 8
Study 22982081 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-Solving Therapy (PST: in-person or telehealth delivery)
Number of subjects: 121
Study 20455367 — intervention group
Group type: EXPERIMENTAL
Intervention: Clark Simulation Evaluation Rubric
Number of subjects: 178
Study 18973065 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine (1.5 mg once a day increment over 4 weeks to 3 mg twice daily)
Number of subjects: 60
Study 18973065 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 18973065 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Rivastigmine and Placebo
Number of subjects: 60
Study 16076046 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenous activated protein C (drotrecogine alpha) included in therapy for sepsis
Number of subjects: 0
Study 12602460 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril 5-20 mg/day
Number of subjects: 397
Study 12602460 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 397
Study 9882083 — intervention group
Group type: EXPERIMENTAL
Intervention: dexketoprofen trometamol 25 mg
Number of subjects: 125
Study 9882083 — intervention group
Group type: EXPERIMENTAL
Intervention: dexketoprofen trometamol 12.5 mg
Number of subjects: 125
Study 9882083 — intervention group
Group type: COMPARATOR
Intervention: dipyrone 575 mg
Number of subjects: 125
Study 7925220 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 g boiled carrots
Number of subjects: 10
Study 7925220 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 g boiled carrots
Number of subjects: 10
Study 7925220 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 g boiled carrots
Number of subjects: 10
Study 7925220 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 g boiled carrots with lactic acid
Number of subjects: 10
Study 7925220 — intervention group
Group type: COMPARATOR
Intervention: Control meal without vegetables
Number of subjects: 10
Study 2635834 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous immunotherapy (SI)
Number of subjects: 28
Study 2635834 — intervention group
Group type: COMPARATOR
Intervention: Oral immunotherapy (OI)
Number of subjects: 28
Study 28675941 — intervention group
Group type: EXPERIMENTAL
Intervention: Schedules, Tools, and Activities for Transitions (STAT) program
Number of subjects: 150
Study 28675941 — intervention group
Group type: COMPARATOR
Intervention: Waitlist (Control)
Number of subjects: 150
Study 26621261 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 136
Study 26621261 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 136
Study 26621261 — intervention group
Group type: COMPARATOR
Intervention: Both escitalopram and nortriptyline
Number of subjects: 136
Study 24841105 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium pyruvate (0.1 g·kg(‐1) of body mass)
Number of subjects: 9
Study 24841105 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 21976386 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin-pegylated liposomal doxorubicin (CD)
Number of subjects: 344
Study 21976386 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin-paclitaxel (CP)
Number of subjects: 344
Study 21135995 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin glue for conjunctival autograft (Group 1)
Number of subjects: 50
Study 21135995 — intervention group
Group type: COMPARATOR
Intervention: Sutures for conjunctival autograft (Group 2)
Number of subjects: 50
Study 18082488 — intervention group
Group type: EXPERIMENTAL
Intervention: MRP-8/14 levels measured at 30 days after acute coronary syndrome
Number of subjects: 237
Study 18082488 — intervention group
Group type: EXPERIMENTAL
Intervention: MRP-8/14 quartiles
Number of subjects: 237
Study 18082488 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated MRP-8/14 and high-sensitivity C-reactive protein
Number of subjects: 237
Study 17081360 — intervention group
Group type: EXPERIMENTAL
Intervention: SCD group (n = 36)
Number of subjects: 90
Study 17081360 — intervention group
Group type: COMPARATOR
Intervention: Control group I (non-SCD CHD, n = 28)
Number of subjects: 90
Study 17081360 — intervention group
Group type: COMPARATOR
Intervention: Control group II (non-cardiac death, n = 26)
Number of subjects: 90
Study 12843739 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV‐1 p24 antigen test (signal amplification‐boosted ELISA of heat‐denatured plasma)
Number of subjects: 55
Study 12843739 — intervention group
Group type: EXPERIMENTAL
Intervention: Batch-wise retesting of samples from patients
Number of subjects: 55
Study 11395246 — intervention group
Group type: COMPARATOR
Intervention: Control (Arm A) - 15 Gy/5 fractions/5 days
Number of subjects: 156
Study 11395246 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperfractionation (Arm B) - 8 Gy/2 fractions/1 day
Number of subjects: 156
Study 11395246 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated Hyperfractionation (Arm C) - 12 Gy/4 fractions/2 days
Number of subjects: 156
Study 9219165 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO)
Number of subjects: 30
Study 9219165 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 7900267 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic NSAID use
Number of subjects: 140
Study 7900267 — intervention group
Group type: COMPARATOR
Intervention: No NSAID use
Number of subjects: 140
Study 3118755 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin discs (30 mg)
Number of subjects: 9
Study 3118755 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 2294222 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet intervention
Number of subjects: 73
Study 1097196 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephradine
Number of subjects: 42
Study 1097196 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin
Number of subjects: 42
Study 31021842 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsoulnar incision
Number of subjects: 46
Study 31021842 — intervention group
Group type: COMPARATOR
Intervention: Early mobilization
Number of subjects: 46
Study 31021842 — intervention group
Group type: COMPARATOR
Intervention: Midline incision
Number of subjects: 46
Study 31021842 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsoulnar incision and immobilization
Number of subjects: 46
Study 28711118 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental imagery training (eight 10-minute sessions every second day via the Internet)
Number of subjects: 30
Study 28711118 — intervention group
Group type: COMPARATOR
Intervention: Wait condition (control group)
Number of subjects: 30
Study 26362659 — intervention group
Group type: EXPERIMENTAL
Intervention: MMRV/MMRV
Number of subjects: 0
Study 26362659 — intervention group
Group type: EXPERIMENTAL
Intervention: MMR/MMRV
Number of subjects: 0
Study 26362659 — intervention group
Group type: COMPARATOR
Intervention: MMR/MMR+V (control group)
Number of subjects: 0
Study 24187865 — intervention group
Group type: EXPERIMENTAL
Intervention: Scraping therapy at acupoint until appearance of skin eruptions
Number of subjects: 210
Study 24187865 — intervention group
Group type: EXPERIMENTAL
Intervention: Scraping therapy along channel until appearance of skin eruptions
Number of subjects: 210
Study 24187865 — intervention group
Group type: EXPERIMENTAL
Intervention: Scraping therapy at acupoint without appearance of skin eruptions
Number of subjects: 210
Study 24187865 — intervention group
Group type: EXPERIMENTAL
Intervention: Scraping therapy along channel without appearance of skin eruptions
Number of subjects: 210
Study 24187865 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 210
Study 21894054 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplement 1,520 IU/daily
Number of subjects: 30
Study 21894054 — intervention group
Group type: COMPARATOR
Intervention: Ultraviolet radiation B (UVB) 6 min weekly
Number of subjects: 30
Study 21894054 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 19746407 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized Controlled Trials (RCT)
Number of subjects: 1627
Study 19746407 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational/Descriptive Studies
Number of subjects: 1627
Study 19746407 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-Analyses
Number of subjects: 1627
Study 19746407 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation Studies
Number of subjects: 1627
Study 19746407 — intervention group
Group type: EXPERIMENTAL
Intervention: Others
Number of subjects: 1627
Study 17727941 — intervention group
Group type: COMPARATOR
Intervention: Stable BMI (+/‐0.5 kg/m(2))
Number of subjects: 13230
Study 17727941 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in BMI >/=2.0 kg/m(2)
Number of subjects: 13230
Study 17727941 — intervention group
Group type: EXPERIMENTAL
Intervention: Decrease in BMI
Number of subjects: 13230
Study 15482031 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided thrombin injection
Number of subjects: 30
Study 15482031 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided compression
Number of subjects: 30
Study 11533565 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training (JG) 3 days/week for 10 weeks
Number of subjects: 20
Study 11533565 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 20
Study 11533565 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced training period (8 weeks) for both groups
Number of subjects: 20
Study 10204428 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-cured resin-modified glass-ionomer adhesive (Fuji Ortho LC)
Number of subjects: 0
Study 10204428 — intervention group
Group type: COMPARATOR
Intervention: Acid-etch chemically-cured composite (Orthodontic Concise)
Number of subjects: 0
Study 8144726 — intervention group
Group type: EXPERIMENTAL
Intervention: Paramedic-initiated thrombolysis
Number of subjects: 0
Study 8144726 — intervention group
Group type: COMPARATOR
Intervention: Hospital-initiated thrombolysis
Number of subjects: 0
Study 3043370 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine (low, medium, and high doses)
Number of subjects: 9
Study 3043370 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 31337437 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour change intervention with classroom-based session (CBS) and SMS reminders to brush teeth twice daily
Number of subjects: 5040
Study 31337437 — intervention group
Group type: COMPARATOR
Intervention: Usual curriculum and no SMS
Number of subjects: 5040
Study 29455504 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary rehabilitation exercise combined with isometric extension of quadriceps femoris
Number of subjects: 90
Study 29455504 — intervention group
Group type: COMPARATOR
Intervention: Apparatus training combined with isometric extension of quadriceps femoris
Number of subjects: 90
Study 29455504 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (experimental and control)
Number of subjects: 90
Study 25923275 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal saline spray and a 3‐day course of antibiotics (either amoxicillin/clavulanate or levofloxacin)
Number of subjects: 50
Study 25923275 — intervention group
Group type: COMPARATOR
Intervention: Nasal saline alone
Number of subjects: 50
Study 23864175 — intervention group
Group type: EXPERIMENTAL
Intervention: Semitendinosus and gracilis tendon group (STG)
Number of subjects: 42
Study 23864175 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone-patellar tendon-bone group (BPTB)
Number of subjects: 42
Study 23864175 — intervention group
Group type: COMPARATOR
Intervention: ACL reconstruction groups (STG and BPTB)
Number of subjects: 42
Study 21494053 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (5 mg)
Number of subjects: 17
Study 21494053 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 18653753 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate (HC) diet (7 g.kg(‐1).day(‐1))
Number of subjects: 7
Study 18653753 — intervention group
Group type: COMPARATOR
Intervention: Low-carbohydrate (LC) diet (2.9 g.kg(‐1).day(‐1))
Number of subjects: 7
Study 16442046 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,450 nm laser alone
Number of subjects: 20
Study 16442046 — intervention group
Group type: COMPARATOR
Intervention: Microdermabrasion plus 1,450 nm laser
Number of subjects: 20
Study 16442046 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 20
Study 14503833 — intervention group
Group type: EXPERIMENTAL
Intervention: Crown-down technique with 0.06 ProFiles series 29 to size 6 (Group 1)
Number of subjects: 60
Study 14503833 — intervention group
Group type: EXPERIMENTAL
Intervention: Step-back technique with 0.06 ProFiles series 29 to size 6 (Group 2)
Number of subjects: 60
Study 14503833 — intervention group
Group type: EXPERIMENTAL
Intervention: Crown-down technique with Greater Taper files (GT files) (Group 3)
Number of subjects: 60
Study 14503833 — intervention group
Group type: EXPERIMENTAL
Intervention: Step-back technique with Greater Taper files (GT files) (Group 4)
Number of subjects: 60
Study 10915748 — intervention group
Group type: COMPARATOR
Intervention: Lamivudine 150 mg/d orally for 12 weeks
Number of subjects: 21
Study 10915748 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine 150 mg/d plus famciclovir 500 mg 3 times a day orally for 12 weeks
Number of subjects: 21
Study 8831468 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate administered twice daily at a dose of .30 mg/kg
Number of subjects: 23
Study 8831468 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered according to the same schedule in identical pill form
Number of subjects: 23
Study 1472662 — intervention group
Group type: EXPERIMENTAL
Intervention: DDAVP (0.3 micrograms/kg), IV, after cardiopulmonary bypass (CPB) and 12 hours later in the ICU
Number of subjects: 70